Table 2. Demographics and laboratory findings of the study population.
| No. of patients | 1816 |
| Age, y, median (IQR) | 69.5 (33) |
| Female sex, n (%) | 982 (54.1) |
| qSOFA score median (IQR) | 1 (2) |
| SOFA score median (IQR) | 4 (7) |
| APACHE II score median (IQR) | 19 (15) |
| Lactate median (IQR) | 2,3 (2.28) |
| Length of stay in i care (day) (IQR) | 4 (5) |
| The need for mechanical ventilation n (%) | 612 (33.7) |
| In-hospital mortality n (%) | 374 (20.6) |
| 6-month mortality n (%) | 796 (43.8) |
| Diagnosis n (%) | 1816 (100) |
| Sepsis and septic shock | 434 (23.9) |
| Poisoning | 338 (18.6) |
| Cerebrovascular disease | 295 (16.2) |
| Respiratory failure | 154 (8.5) |
| ROSC after CA | 117 (6.4) |
| Acute renal failure | 97 (5.3) |
| Diabetic ketoacidosis | 94 (5.2) |
| Decompensated heart failure | 92 (5.1) |
| Gastrointestinal hemorrhage | 83 (4.6) |
| Pulmonary thromboembolism | 34 (1.9) |
| Status epilepticus | 31 (1.7) |
| Liver failure | 20 (1.1) |
| Anaphylactic shock | 14 (0.8) |
| Multiple trauma | 12 (0.7) |
| Eclampsia | 1 (0.1) |
| Resume n (%) | 1816 (100) |
| Hypertension | 780 (42.9) |
| Diabetes mellitus | 596 (32.8) |
| Coronary artery disease | 378 (20.8) |
| Cerebrovascular disease | 160 (8.8) |
| Heart failure | 283 (15.6) |
| COPD / Asthma | 223 (12.3) |
| Alzheimer’s | 84 (4.6) |
| Cancer | 60 (3.3) |
| Chronic renal disease | 53 (2.9) |
| Chronic liver disease | 16 (0.9) |
| Hyperlipidemia | 45 (2.5) |
| Epilepsy | 34 (1.9) |
APACHE, Acute Physiology and Chronic Health Evaluation; COPD, Chronic Obstructive Pulmonary Disease; ROSC after CA, return of spontaneous circulation after cardiac arrest; SOFA, Sequential Organ Failure Assessment; qSOFA, quick sequential organ failure assessment.